Incorporation of metabolic enzymes to improve predictivity of reporter gene assay results for estrogenic and anti-androgenic activity.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Reproductive Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.reprotox.2017.11.005PMID 29162470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incorporation of a metabolizing system in biodetection assays for endocrine active substances.

  2017cited by this paper
• Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.

  2015cited by this paper
• A Curated Database of Rodent Uterotrophic Bioactivity

  2015cited by this paper
• A high throughput screening system for predicting chemically-induced reproductive organ deformities.

  2015cited by this paper
• Evaluation of an alternative in vitro test battery for detecting reproductive toxicants in a grouping context.

  2015cited by this paper
• A review on endocrine disruptors and their possible impacts on human health.

  2015cited by this paper
• INTRODUCTION TO ENDOCRINE DISRUPTING CHEMICALS (EDCs) A GUIDE FOR PUBLIC INTEREST ORGANIZATIONS AND POLICY-MAKERS

  2014cited by this paper
• Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress.

  2014cited by this paper
• EURL ECVAM Status Report on the Development, Validation and Regulatory Acceptance of Alternative Methods and Approaches (2013-April 2014)

  2014cited by this paper
• AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.

  2014cited by this paper
• A Panel of Quantitative Calux® Reporter Gene Assays for Reliable High‐Throughput Toxicity Screening of Chemicals and Complex Mixtures

  2013cited by this paper
• In vitro metabolism and bioavailability tests for endocrine active substances: what is needed next for regulatory purposes?

  2013cited by this paper
• Evaluation of an alternative in vitro test battery for detecting reproductive toxicants.

  2013cited by this paper
• Guidance Document on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption

  2012cited by this paper
• Additive Mixture Effects of Estrogenic Chemicals in Human Cell-Based Assays Can Be Influenced by Inclusion of Chemicals with Differing Effect Profiles

  2012cited by this paper
• Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

  2012cited by this paper
• Use of external metabolizing systems when testing for endocrine disruption in the T-screen assay.

  2011cited by this paper
• Metabolism of parabens (4-hydroxybenzoic acid esters) by hepatic esterases and UDP-glucuronosyltransferases in man.

  2010cited by this paper
• Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.

  2010cited by this paper
• Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay.

  2008cited by this paper
• Selected Titles

  2006cited by this paper
• Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.

  2006cited by this paper
• Steroid receptor profiling of vinclozolin and its primary metabolites.

  2006cited by this paper
• CHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450

  2005cited by this paper
• Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen

  2004cited by this paper
• Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.

  2004cited by this paper
• Metabolism and kinetics of bisphenol a in humans at low doses following oral administration.

  2002cited by this paper
• Detection of estrogenic activity in sediment-associated compounds using in vitro reporter gene assays.

  2002cited by this paper
• Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action.

  2002cited by this paper
• Incorporation of S-9 activation into an ER-α transactivation assay☆

  2000cited by this paper
• Incorporation of S-9 activation into an ER-alpha transactivation assay.

  2000cited by this paper
• Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.

  2000cited by this paper
• Several environmental oestrogens are also anti-androgens.

  1998cited by this paper
• Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop.

  1996cited by this paper
• Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptor.

  1992cited by this paper
• Identifying environmental chemicals causing mutations and cancer.

  1979cited by this paper

• No distinct estrogenic or androgenic activity was observed in Korean red ginseng metabolites prepared using a S9 system

  2026cites this paper
• On the Utilization and Characterization of External Biotransformation Systems in In Vitro Toxicology: A Critical Review of the Scientific Literature with Guidance Recommendations

  2025cites this paper
• New Approach Methodologies for evaluating Developmental And Reproductive Toxicity potential: review on state of the art, applicability for cosmetic related ingredients and coverage of developmental stages

  2025cites this paper
• Establishing scientific confidence in a two-chamber co-culture system to evaluate androgenic response in the presence of hepatic metabolism.

  2025cites this paper
• Testing Strategies for Metabolite-Mediated Neurotoxicity

  2025cites this paper
• S9 metabolism integrated CALUX® assay reveals invisible endocrine activities of sediments from two eutrophic freshwater lakes in China.

  2025cites this paper
• Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: Benzophenone-4 case study.

  2025cites this paper
• A three-dimensional mouse liver organoid platform for assessing EDCs metabolites simulating liver metabolism.

  2025cites this paper
• Advancing in vitro assessment of iodide uptake inhibition: integrating a novel biotransformation pretreatment step

  2025cites this paper
• Estrogenic, androgenic, and genotoxic activities of zearalenone and deoxynivalenol in in vitro bioassays including exogenous metabolic activation

  2024cites this paper
• Next-generation risk assessment read-across case study: application of a 10-step framework to derive a safe concentration of daidzein in a body lotion

  2024cites this paper
• Confirmation of the steroid hormone receptor-mediated endocrine disrupting potential of fenvalerate following the Organization for Economic Cooperation and Development test guidelines, and its estrogen receptor α-dependent effects on lipid accumulation.

  2024cites this paper
• Development of a human liver microphysiological co-culture system for higher throughput chemical safety assessment.

  2024cites this paper
• Evaluation of new alternative methods for the identification of estrogenic, androgenic and steroidogenic effects: a comparative in vitro/in silico study

  2023cites this paper
• Replacing animal-derived components in in vitro test guidelines OECD 455 and 487.

  2023cites this paper
• Development of a microphysiological skin-liver-thyroid Chip3 model and its application to evaluate the effects on thyroid hormones of topically applied cosmetic ingredients under consumer-relevant conditions

  2023cites this paper
• Curcumol metabolized by rat liver S9 fraction and orally administered in mouse suppressed the proliferation of colon cancer in vitro and in vivo

  2023cites this paper
• Comprehensive Evaluation System for Post-Metabolic Activity of Potential Thyroid-Disrupting Chemicals

  2023cites this paper
• Human Androgen Receptor-Mediated Endocrine Disrupting Potential of Parabens and Triclosan

  2023cites this paper
• Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors

  2023cites this paper
• Azole pesticide products and their hepatic metabolites cause endocrine disrupting potential by suppressing the homo-dimerization of human estrogen receptor alpha.

  2022cites this paper
• Volatile bioactive compounds from marine macro-algae and their pharmacological properties

  2022cites this paper
• Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicals.

  2022cites this paper
• Safe food for infants: an EU-China project to enhance the control of safety risks raised by microbial and chemical hazards all along the infant food chains

  2022cites this paper
• Spatial and temporal variations in anti-androgenic activity and environmental risk in a small river.

  2022cites this paper
• Biodegradation of Fipronil: Transformation Products, Microbial Characterisation and Toxicity Assessment

  2021cites this paper
• Paleotoxicity of petrogenic and pyrogenic hydrocarbon mixtures in sediment cores from the Athabasca oil sands region, Alberta (Canada).

  2021cites this paper
• Reliability of the AR-CALUX®In Vitro Method Used to Detect Chemicals with (Anti)Androgen Activity: Results of an International Ring Trial

  2021cites this paper
• Induction of AhR transactivation by PBDD/Fs and PCDD/Fs using a novel human-relevant, high-throughput DRhuman CALUX reporter gene assay.

  2021cites this paper
• A systematic approach to metabolic characterization of thyroid-disrupting chemicals and their in vitro biotransformants based on prediction-assisted metabolomic analysis.

  2021cites this paper
• Versicolorin A enhances the genotoxicity of Aflatoxin B1 in human liver cells by inducing the transactivation of the Ah-Receptor.

  2021cites this paper
• Endocrine disrupting potential of veterinary drugs by in vitro stably transfected human androgen receptor transcriptional activation assays.

  2021cites this paper
• Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals

  2020cites this paper
• Screening of potential oestrogen receptor α agonists in pesticides via in silico, in vitro and in vivo methods.

  2020cites this paper
• The Alginate Immobilization of Metabolic Enzymes (AIME) Platform Retrofits an Estrogen Receptor Transactivation Assay with Metabolic Competence.

  2020cites this paper
• Antagonistic activity towards the androgen receptor independent from natural sex hormones in human milk samples from the Norwegian HUMIS cohort.

  2020cites this paper
• The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods

  2020cites this paper
• Organisation for Economic Cooperation and Development

  2020cites this paper
• Evaluation of a multiplexed, multispecies nuclear receptor assay for chemical hazard assessment.

  2020cites this paper
• Paradigm shift in safety assessment using new approach methods: The EU-ToxRisk strategy

  2019cites this paper
• Evaluation of androgen assay results using a curated Hershberger database.

  2018cites this paper
• Using bisphenol A and its analogs to address the feasibility and usefulness of the CALUX-PPARγ assay to identify chemicals with obesogenic potential.

  2018cites this paper
• The Role of Metabolism in the Estrogenic Activity of Endocrine-Disrupting Chemicals

  2018cites this paper